Why some don't get emphysema

finds that Nrf2 protects against inflammation and destruction of lungs

Written byXavier Bosch
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Nrf2—a protein involved in protecting against oxidative stress—is critical in the protection of the lungs in mice against the inflammation and destruction typical of emphysema, a team of researchers at Johns Hopkins University Bloomberg School of Public Health report in the November 1 issue of the Journal of Clinical Investigation. The finding could explain why only a tiny fraction of heavy cigarette smokers develop severe forms of the disease, according to Shyam Biswal and colleagues, since while all humans have Nrf2, the genetically determined responsiveness of the Nrf2 pathway may act as a major determinant of susceptibility to tobacco smoke–induced emphysema.

Biswal and colleagues subjected Nrf2-deficient mice as well as wildtype ICR strain mice to chronic cigarette smoke by burning cigarettes using a smoking machine. The authors found a dramatic increase in alveolar destruction in the lungs of Nrf2-deficient mice when compared with wildtype mice after 6 months of exposure. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies